Pessary is device inserted into the vagina to support sagging organs that have dropped down (prolapsed) or to help control urine leakage.
To treat POP, vaginal mesh is a medical device that is used to provide extra support when repairing weakened or damaged vaginal wall. Surgery can be done through the abdomen (transabdominal) or through the vagina (transvaginal).
Scope of the Report:
The global production volume of vaginal pessary was 9305 K Units in 2016. The two regions are expected to dominate both the production and consumption of vaginal pessary in the years to come. Overall, the vaginal pessary products performance is positive with the global economic recovery.
The technical barriers of vaginal pessary are high, resulting in fewer manufacturing enterprises. For vaginal pessary market, the key players are CooperSurgical, MedGyn and Personal Medical Corp. The market of vaginal Pessary is more separated, with the top four players takes 37.53% of global production market share in 2016.
In the past few years, the price of vaginal pessary has slightly increased and we expect the price will keep increase slightly as the growing of raw material cost.
The application of vaginal pessary can be broadly classified as Stress Urinary Incontinence, Severe Pelvic Organ Prolapse, and Mild Pelvic Organ Prolapse in terms of function. Mild Pelvic Organ Prolapse is the major application of vaginal pessary which takes consumption share of 75.68% in 2016. Vaginal pessary can also replace surgery in Severe Pelvic Organ Prolapse occasions. Polypropylene mesh (PPM) was never shown to be safe and effective for the treatment of Pelvic Organ Prolapse. Although PPM had been used for decades in the treatment of abdominal hernias, it was dangerous to assume that it would be fine to use in the vagina. Generally, vaginal pessary is the most safe way for Pelvic Organ Prolapse in the current situation.
The worldwide market for Vaginal Pessary is expected to grow at a CAGR of roughly 4.8% over the next five years, will reach 270 million US$ in 2024, from 200 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Vaginal Pessary in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Personal Medical Corp
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Mild Pelvic Organ Prolapse
Stress Urinary Incontinence
Severe Pelvic Organ Prolapse
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaginal Pessary product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaginal Pessary, with price, sales, revenue and global market share of Vaginal Pessary in 2017 and 2018.
Chapter 3, the Vaginal Pessary competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaginal Pessary breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vaginal Pessary market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vaginal Pessary sales channel, distributors, customers, research findings and conclusion, appendix and data source.